Marksans Pharma and Sun Biophamrmaceuticals Industries are facilitating recalls through the FDA of their drug Metaformin as a result of high NDMA (N-nitrosodimethylamine) it contains. The FDA released a comprehensive list of Metaformin products being recalled. It is advised for emergency patients, especially patients with Type 2 Diabetes to not cease their dosage until provided a supplement drug.

Read more here.

More on: